Cardiac Imaging in Oncology Trials: The Benefits of Advanced Imaging Management Systems

During oncologic drug development, clinical trial sponsors often are required to utilize imaging for monitoring cardiotoxicity. For these cardiac safety trials, as in all trials involving imaging, it matters how images are taken, how they are analyzed, and how the process is monitored.

This article presents how sponsors can optimize imaging processes in oncology clinical trials to demonstrate the cardiac safety of their compounds more efficiently, and how the quality and capabilities of the imaging management system can have an appreciable impact on trial costs and timelines.